BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis. Trop Med Infect Dis. 2020;5. [PMID: 32429038 DOI: 10.3390/tropicalmed5020080] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu C, Zhang T, Zhu N, Han M. Characteristics of COVID-19 patients with preexisting CKD history. Int Urol Nephrol 2021. [PMID: 33674950 DOI: 10.1007/s11255-021-02819-5] [Reference Citation Analysis]
2 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532 [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig Liver Dis. 2021;53:146-152. [PMID: 32988758 DOI: 10.1016/j.dld.2020.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
4 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Shakaib B, Zohra T, Ikram A, Shakaib MB, Ali A, Bashir A, Salman M, Khan MA, Ansari J. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? Virol J 2021;18:120. [PMID: 34098986 DOI: 10.1186/s12985-021-01578-0] [Reference Citation Analysis]
6 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Reference Citation Analysis]
7 Lami F, Elfadul M, Rashak HA, Al Nsour M, Akhtar H, Khader YS, Hussein AM, Naciri M, Samy S, Ghaleb Y, Taha HA, Aljanabe AH, Ali NA, Zayer RH, Ikram A, Rahman FU, Khan MM, Adam R, Ahmed AY, Afifi S. Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: A Multicountry Retrospective Study . JMIR Public Health Surveill 2021. [PMID: 34736222 DOI: 10.2196/32831] [Reference Citation Analysis]
8 Xie L, Lin Y, Deng Y, Lei B. The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes. Viral Immunol 2021;34:416-20. [PMID: 33902347 DOI: 10.1089/vim.2020.0320] [Reference Citation Analysis]
9 Ateya AM. CKD patients: A high-risk category for severe COVID-19. J Med Virol 2021;93:4086-7. [PMID: 33704811 DOI: 10.1002/jmv.26929] [Reference Citation Analysis]
10 An Y, Ma Z, Guo X, Tang Y, Meng H, Yu H, Peng C, Chu G, Wang X, Teng Y, Zhang Q, Zhu T, Wang B, Tong Z, Zhao H, Lu H, Qi X. Comparison of liver biochemical abnormality between COVID-19 patients with liver cirrhosis versus COVID-19 alone and liver cirrhosis alone: A STROBE observational study. Medicine (Baltimore) 2021;100:e25497. [PMID: 34106589 DOI: 10.1097/MD.0000000000025497] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Al-Zaidan L, Mestiri S, Raza A, Merhi M, Inchakalody VP, Fernandes Q, Taib N, Uddin S, Dermime S. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Tumour Biol 2021;43:177-96. [PMID: 34420993 DOI: 10.3233/TUB-200084] [Reference Citation Analysis]
12 Khedr EM, Daef E, Mohamed-Hussein A, Mostafa EF, Zein M, Hassany SM, Galal H, Hassan SA, Galal I, Zarzour AA, Hetta HF, Hassan HM, Amin MT, Hashem MK. Impact of comorbidities on COVID-19 outcome. medRxiv 2020:2020. [PMID: 34013292 DOI: 10.1101/2020.11.28.20240267] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Alqahtani JS, Mendes RG, Aldhahir A, Rowley D, AlAhmari MD, Ntoumenopoulos G, Alghamdi SM, Sreedharan JK, Aldabayan YS, Oyelade T, Alrajeh A, Olivieri C, AlQuaimi M, Sullivan J, Almeshari MA, Esquinas A. Global Current Practices of Ventilatory Support Management in COVID-19 Patients: An International Survey. J Multidiscip Healthc 2020;13:1635-48. [PMID: 33239884 DOI: 10.2147/JMDH.S279031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
14 Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Reference Citation Analysis]
15 Xiao W, Xu J, Liang X, Shi L, Zhang P, Wang Y, Yang H. Relationship between chronic kidney disease and adverse outcomes of coronavirus disease 2019: a meta-analysis based on adjusted risk estimates. Int Urol Nephrol 2021;53:1723-7. [PMID: 33387218 DOI: 10.1007/s11255-020-02748-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sgouropoulou V, Vargiami E, Kyriazi M, Papadimitriou E, Agakidis C, Zafeiriou D. Transient Severe Liver Injury: A Unique Presentation of COVID-19 Disease in a Pediatric Patient. Pediatr Infect Dis J 2021;40:e204-5. [PMID: 33591082 DOI: 10.1097/INF.0000000000003104] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 . Retraction notice for: "Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases." Theodoros V. Giannouchos, Roberto A. Sussman, José M. Mier, Konstantinos Poulas and Konstantinos Farsalinos. Eur Respir J 2020; in press. Eur Respir J 2021;57:2002144. [PMID: 32732325 DOI: 10.1183/13993003.02144-2020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 34] [Article Influence: 18.0] [Reference Citation Analysis]
18 Sarkar S, Khanna P, Singh AK. Impact of COVID-19 in patients with concurrent co-infections: A systematic review and meta-analyses. J Med Virol 2021;93:2385-95. [PMID: 33331656 DOI: 10.1002/jmv.26740] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
19 [DOI: 10.1101/2020.06.04.20122481] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Albadawy RM, Jadoon BA, Mogahed MM, Ibrahim ME, Essawy TS, Amin AMA, Abd-Elraouf MS, Elawady MA. The Impact of Comorbidities on the Outcomes of Egyptian COVID-19 Patients: A Follow-Up Study. J Environ Public Health 2021;2021:6662476. [PMID: 34239576 DOI: 10.1155/2021/6662476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis. PLoS One 2021;16:e0250602. [PMID: 33939733 DOI: 10.1371/journal.pone.0250602] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
22 Giannis D, Allen SL, Tsang J, Flint S, Pinhasov T, Williams S, Tan G, Thakur R, Leung C, Snyder M, Bhatia C, Garrett D, Cotte C, Isaacs S, Gugerty E, Davidson A, Marder GS, Schnitzer A, Goldberg B, McGinn T, Davidson KW, Barish MA, Qiu M, Zhang M, Goldin M, Matsagkas M, Arnaoutoglou E, Spyropoulos AC. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood 2021;137:2838-47. [PMID: 33824972 DOI: 10.1182/blood.2020010529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
23 Nikoloski Z, Alqunaibet AM, Alfawaz RA, Almudarra SS, Herbst CH, El-Saharty S, Alsukait R, Algwizani A. Covid-19 and non-communicable diseases: evidence from a systematic literature review. BMC Public Health 2021;21:1068. [PMID: 34090396 DOI: 10.1186/s12889-021-11116-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52:584-599. [PMID: 32638436 DOI: 10.1111/apt.15916] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 29.5] [Reference Citation Analysis]
25 Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
26 Hoang T, Tran Thi Anh T. Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis. Infect Chemother 2021;53:13-28. [PMID: 34409779 DOI: 10.3947/ic.2020.0136] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Dong G, Du Z, Zhu J, Guo Y, Gao W, Guo W, Wang T, Jiang B. The clinical characteristics and prognosis of COVID-19 patients with comorbidities: a retrospective analysis of the infection peak in Wuhan. Ann Transl Med 2021;9:280. [PMID: 33708907 DOI: 10.21037/atm-20-4052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G. Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology 2020;72:1864-72. [PMID: 32702162 DOI: 10.1002/hep.31480] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 32.0] [Reference Citation Analysis]
29 Choi GJ, Kim HM, Kang H. The Potential Role of Dyslipidemia in COVID-19 Severity: an Umbrella Review of Systematic Reviews. J Lipid Atheroscler 2020;9:435-48. [PMID: 33024735 DOI: 10.12997/jla.2020.9.3.435] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
30 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
31 Bajgain KT, Badal S, Bajgain BB, Santana MJ. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. Am J Infect Control 2021;49:238-46. [PMID: 32659414 DOI: 10.1016/j.ajic.2020.06.213] [Cited by in Crossref: 43] [Cited by in F6Publishing: 55] [Article Influence: 21.5] [Reference Citation Analysis]
32 Kayaaslan B, Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021; 13(12): 2013-2023 [DOI: 10.4254/wjh.v13.i12.2013] [Reference Citation Analysis]
33 Kovalic AJ, Satapathy SK, Thuluvath PJ. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int. 2020;14:612-620. [PMID: 32725453 DOI: 10.1007/s12072-020-10078-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
34 Calleri A, Saracco M, Pittaluga F, Cavallo R, Romagnoli R, Martini S. Seroconversion After Coronavirus Disease 2019 Vaccination in Patients Awaiting Liver Transplantation: Fact or Fancy? Liver Transpl 2021. [PMID: 34564945 DOI: 10.1002/lt.26312] [Reference Citation Analysis]
35 Ma C, Tu D, Gu J, Xu Q, Hou P, Wu H, Guo Z, Bai Y, Zhao X, Li P. The Predictive Value of Myoglobin for COVID-19-Related Adverse Outcomes: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:757799. [PMID: 34869669 DOI: 10.3389/fcvm.2021.757799] [Reference Citation Analysis]
36 Granger C, Guedeney P, Arnaud C, Guendouz S, Cimadevilla C, Kerneis M, Kerneis C, Zeitouni M, Verdonk C, Legeai C, Lebreton G, Leprince P, Désiré E, Sorrentino S, Silvain J, Montalescot G, Hazan F, Varnous S, Dorent R. Clinical manifestations and outcomes of coronavirus disease-19 in heart transplant recipients: a multicentre case series with a systematic review and meta-analysis. Transpl Int 2021;34:721-31. [PMID: 33539616 DOI: 10.1111/tri.13837] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Cheng Y, Wang W, Wu L, Cai G. SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges. SN Compr Clin Med 2020;:1-10. [PMID: 32984768 DOI: 10.1007/s42399-020-00529-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Sethumadhavan DV, Jabeena CA, Govindaraju G, Soman A, Rajavelu A. The severity of SARS-CoV-2 infection is dictated by host factors? Epigenetic perspectives. Curr Res Microb Sci 2021;2:100079. [PMID: 34725650 DOI: 10.1016/j.crmicr.2021.100079] [Reference Citation Analysis]
39 Téllez L, Martín Mateos RM. COVID-19 and liver disease: An update. Gastroenterol Hepatol 2020;43:472-80. [PMID: 32727662 DOI: 10.1016/j.gastrohep.2020.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
40 Rabbani G, Shariful Islam SM, Rahman MA, Amin N, Marzan B, Robin RC, Alif SM. Pre-existing COPD is associated with an increased risk of mortality and severity in COVID-19: a rapid systematic review and meta-analysis. Expert Review of Respiratory Medicine 2021;15:705-16. [DOI: 10.1080/17476348.2021.1866547] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
41 Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology 2020;:1-12. [PMID: 33296901 DOI: 10.1159/000512592] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
42 Casas-Deza D, Bernal-Monterde V, Aranda-Alonso AN, Montil-Miguel E, Julián-Gomara AB, Letona-Giménez L, Arbones-Mainar JM. Age-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes. PLoS One 2021;16:e0261061. [PMID: 34882740 DOI: 10.1371/journal.pone.0261061] [Reference Citation Analysis]
43 Jdiaa SS, Mansour R, El Alayli A, Gautam A, Thomas P, Mustafa RA. COVID-19 and chronic kidney disease: an updated overview of reviews. J Nephrol 2022. [PMID: 35013985 DOI: 10.1007/s40620-021-01206-8] [Reference Citation Analysis]
44 Liu XQ, Xue S, Xu JB, Ge H, Mao Q, Xu XH, Jiang HD. Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China. Acta Pharmacol Sin 2021. [PMID: 33742107 DOI: 10.1038/s41401-021-00627-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Afify S, Eysa B, Hamid FA, Abo-Elazm OM, Edris MA, Maher R, Abdelhalim A, Abdel Ghaffar MM, Omran DA, Shousha HI. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 2021; 27(42): 7362-7375 [PMID: 34876795 DOI: 10.3748/wjg.v27.i42.7362] [Reference Citation Analysis]
46 Dadson P, Tetteh CD, Rebelos E, Badeau RM, Moczulski D. Underlying Kidney Diseases and Complications for COVID-19: A Review. Front Med (Lausanne) 2020;7:600144. [PMID: 33330565 DOI: 10.3389/fmed.2020.600144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Rastad H, Ejtahed HS, Shafiee G, Safari A, Shahrestanaki E, Khodaparast Z, Hassani NS, Rezaei M, Nazari M, Zakani A, Niksima MM, Azimzadeh M, Karimi F, Tajbakhsh R, Qorbani M. The risk factors associated with COVID-19-Related death among patients with end-stage renal disease. BMC Nephrol 2021;22:33. [PMID: 33468081 DOI: 10.1186/s12882-020-02221-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Aw SB, Teh BT, Ling GHT, Leng PC, Chan WH, Ahmad MH. The COVID-19 Pandemic Situation in Malaysia: Lessons Learned from the Perspective of Population Density. Int J Environ Res Public Health 2021;18:6566. [PMID: 34207205 DOI: 10.3390/ijerph18126566] [Reference Citation Analysis]
49 Joy M, Hobbs FR, Bernal JL, Sherlock J, Amirthalingam G, McGagh D, Akinyemi O, Byford R, Dabrera G, Dorward J, Ellis J, Ferreira F, Jones N, Oke J, Okusi C, Nicholson BD, Ramsay M, Sheppard JP, Sinnathamby M, Zambon M, Howsam G, Williams J, de Lusignan S. Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England. Br J Gen Pract 2020;70:e890-8. [PMID: 33077508 DOI: 10.3399/bjgp20X713393] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
50 Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl 2021;27:1312-25. [PMID: 34096188 DOI: 10.1002/lt.26194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Kirby JJ, Shaikh S, Bryant DP, Ho AF, d'Etienne JP, Schrader CD, Wang H. A Simplified Comorbidity Evaluation Predicting Clinical Outcomes Among Patients With Coronavirus Disease 2019. J Clin Med Res 2021;13:237-44. [PMID: 34007362 DOI: 10.14740/jocmr4476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]